Matches in SemOpenAlex for { <https://semopenalex.org/work/W1577527720> ?p ?o ?g. }
- W1577527720 abstract "ANCA associated vasculitis (AAV) is a heterogeneous group of diseases characterised by sterile pauci-immune systemic small vessel inflammation and closely associated with the presence of anti-neutrophil cytoplasmatic antibodies (ANCA). Although AAV can affect any organ, the kidney, skin, lungs and upper and lower airways are most commonly involved. In some patients there is granuloma formation and in some asthma and eosinophilia, and based on this patients can be further classified as microscopic polyangiitis (MPA) (no granuloma), granulomatosis with polyangiitis (GPA) or eosinophil granulomatosis with polyangiitis (EGPA). Induction treatment of AAV consists of a cytotoxic agent in combination with glucocorticoids and is usually effective, although relapse, infections and drug toxicity remain a problem. The aim of this thesis was to investigate the role of novel proinflammatory molecules in the pathogenesis of AAV and as markers of disease. We also wanted to investigate the outcome of new therapies. In paper I we investigated the pro-inflammatory mediator high-mobility group box-1 protein (HMGB1) in patients with active AAV and in remission. Elevated levels of circulating HMGB1 were found in active disease compared to inactive disease. We found increased expression of HMGB1 in renal tissue of patients with active renal AAV compared to inactive AAV, indicating a role for HMGB1 in AAV. In paper II we carried out a long time follow-up on patients treated with rituximab as a second line treatment in patients with refractory or relapsing disease. We found that a high proportion of patients achieved remission but there were several adverse events including two cases of hepatitis B reactivation. Patients with a negative conventional ANCA but positive capture ANCA seemed to be at risk of relapse after rituximab treatment. In paper III macrophage inhibitory factor and thyroid hormones were investigated prospectively in 30 patients with active AAV. We found that levels of MIF were elevated in active disease compared to remission and that MIF levels correlated with disease activity. There were thyroid hormone alterations with lower triiodothyronine in active disease, similar to what has previously been described in critically ill patients. In addition there was an indication of an interaction between MIF and thyroxine similar to what has previously been described in sepsis. In paper IV we investigated pentraxin – 3 (PTX3) and soluable Tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) in 40 patients with active AAV and found that PTX3 was elevated in active disease compared to remission and correlated with disease severity. sTWEAK levels in active disease did not significantly change compared to remission, but seemed to vary with disease phenotype. Patients with high sTWEAK and low PTX3 were less likely to achieve remission. In conclusion several proinflammatory molecules may be implicated in the pathogenesis and exacerbation of AAV and are possible targets of therapy. There seems to be thyroid hormone alterations in active AAV and there may be an interaction between MIF and thyroxine in AAV. PTX3 may be a useful marker of disease. Rituximab may be a useful treatment in refractory or relapsing disease but it is important to assess hepatitis status and adverse events are a concern. LIST OF SCIENTIFIC PAPERS This thesis is based on the following papers, which will be referred to in the text by their Roman numerals. I. Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, Palmblad K and Gunnarsson I. ”High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations” Mol Med. 2011 17: 29-35. II. Wendt M, Gunnarsson I, Bratt J and Bruchfeld A.”Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients” Scand J Rheumatol. 2012 41:116-9. III. Wendt M, Borjesson O, Avik A, Bratt J, Anderstam B, Qureshi AR, Miller EJ, Gunnarsson I and Bruchfeld A. ”Macrophage Migration Inhibitory Factor (MIF) and Thyroid Hormone Alterations in Antineutrophil Cytoplasmatic Antibody (ANCA)-Associated Vasculitis (AAV)” Mol Med. 2013 20:109-14. IV. M Wendt, O Borjesson, A Avik, J Bratt, AR Qureshi, I Gunnarsson and A Bruchfeld. PTX3 and soluble TWEAK levels in active ANCA associated vasculitis (AAV) patients undergoing treatment – correlation to disease activity and relapse” Manuscript CONTENTS" @default.
- W1577527720 created "2016-06-24" @default.
- W1577527720 creator A5048236703 @default.
- W1577527720 date "2014-12-19" @default.
- W1577527720 modified "2023-09-23" @default.
- W1577527720 title "Clinical and molecular studies in ANCA associated vasculitis" @default.
- W1577527720 cites W107653729 @default.
- W1577527720 cites W1482409286 @default.
- W1577527720 cites W1519476263 @default.
- W1577527720 cites W1558813989 @default.
- W1577527720 cites W157415499 @default.
- W1577527720 cites W1585554327 @default.
- W1577527720 cites W1860589873 @default.
- W1577527720 cites W1862455332 @default.
- W1577527720 cites W1957540688 @default.
- W1577527720 cites W1964800579 @default.
- W1577527720 cites W1964917126 @default.
- W1577527720 cites W1967062775 @default.
- W1577527720 cites W1972204333 @default.
- W1577527720 cites W1975349664 @default.
- W1577527720 cites W1979398789 @default.
- W1577527720 cites W1980302641 @default.
- W1577527720 cites W1980974790 @default.
- W1577527720 cites W1981535363 @default.
- W1577527720 cites W1982860902 @default.
- W1577527720 cites W1983443399 @default.
- W1577527720 cites W1984702041 @default.
- W1577527720 cites W1988635988 @default.
- W1577527720 cites W1990393482 @default.
- W1577527720 cites W1992270926 @default.
- W1577527720 cites W1993041716 @default.
- W1577527720 cites W1997553246 @default.
- W1577527720 cites W1998653773 @default.
- W1577527720 cites W1999511105 @default.
- W1577527720 cites W2003875810 @default.
- W1577527720 cites W2004266769 @default.
- W1577527720 cites W2005790431 @default.
- W1577527720 cites W2006765980 @default.
- W1577527720 cites W2007151357 @default.
- W1577527720 cites W2009150197 @default.
- W1577527720 cites W2011309580 @default.
- W1577527720 cites W2016976168 @default.
- W1577527720 cites W2017094546 @default.
- W1577527720 cites W2019274057 @default.
- W1577527720 cites W2023473273 @default.
- W1577527720 cites W2024644107 @default.
- W1577527720 cites W2024930078 @default.
- W1577527720 cites W2025060860 @default.
- W1577527720 cites W2030638984 @default.
- W1577527720 cites W2031517139 @default.
- W1577527720 cites W2041565487 @default.
- W1577527720 cites W2043756611 @default.
- W1577527720 cites W2053641957 @default.
- W1577527720 cites W2055778617 @default.
- W1577527720 cites W2056615949 @default.
- W1577527720 cites W2057418352 @default.
- W1577527720 cites W2058416888 @default.
- W1577527720 cites W2058825081 @default.
- W1577527720 cites W2059448081 @default.
- W1577527720 cites W2060124860 @default.
- W1577527720 cites W2061274505 @default.
- W1577527720 cites W2062451100 @default.
- W1577527720 cites W2063100698 @default.
- W1577527720 cites W2063340779 @default.
- W1577527720 cites W2064011553 @default.
- W1577527720 cites W2065132929 @default.
- W1577527720 cites W2065724704 @default.
- W1577527720 cites W206701898 @default.
- W1577527720 cites W2068949553 @default.
- W1577527720 cites W2071333258 @default.
- W1577527720 cites W2071782320 @default.
- W1577527720 cites W2073208829 @default.
- W1577527720 cites W2073742622 @default.
- W1577527720 cites W2073779674 @default.
- W1577527720 cites W2073843759 @default.
- W1577527720 cites W2075218891 @default.
- W1577527720 cites W2079531926 @default.
- W1577527720 cites W2080428274 @default.
- W1577527720 cites W2080567030 @default.
- W1577527720 cites W2080681517 @default.
- W1577527720 cites W2081213802 @default.
- W1577527720 cites W2081738712 @default.
- W1577527720 cites W2084056567 @default.
- W1577527720 cites W2090056328 @default.
- W1577527720 cites W2097043422 @default.
- W1577527720 cites W2097310164 @default.
- W1577527720 cites W2097612833 @default.
- W1577527720 cites W2100809783 @default.
- W1577527720 cites W2102133319 @default.
- W1577527720 cites W2104587334 @default.
- W1577527720 cites W2104599968 @default.
- W1577527720 cites W2106550996 @default.
- W1577527720 cites W2107254198 @default.
- W1577527720 cites W2107368919 @default.
- W1577527720 cites W2109774040 @default.
- W1577527720 cites W2118217258 @default.
- W1577527720 cites W2118702066 @default.
- W1577527720 cites W2118814300 @default.
- W1577527720 cites W2119900188 @default.
- W1577527720 cites W2121602116 @default.